LON:FUM

Futura Medical Share Forecast, Price & News

GBX 39.70
-0.10 (-0.25 %)
(As of 08/2/2021 12:00 AM ET)
Add
Compare
Today's Range
39
40
50-Day Range
36.50
48
52-Week Range
12.15
84
Volume269,330 shs
Average Volume1.72 million shs
Market Capitalization£113.97 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive FUM News and Ratings via Email

Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter.


Futura Medical logo

About Futura Medical

Futura Medical plc, a pharmaceutical company, researches and develops pharmaceutical drugs and medical devices for the consumer healthcare markets focusing on sexual health and pain relief management. The company offers CSD500, a condom that contains erectogenic gel. It is also developing MED3000, a topical gel for the treatment of erectile dysfunction that has completed Phase III clinical trials. In addition, the company develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.55 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Futura Medical (LON:FUM) Frequently Asked Questions

Is Futura Medical a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Futura Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Futura Medical stock.
View analyst ratings for Futura Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Futura Medical?

Wall Street analysts have given Futura Medical a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Futura Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Futura Medical's next earnings date?

Futura Medical is scheduled to release its next quarterly earnings announcement on Tuesday, September 14th 2021.
View our earnings forecast for Futura Medical
.

How were Futura Medical's earnings last quarter?

Futura Medical plc (LON:FUM) posted its quarterly earnings results on Wednesday, September, 16th. The company reported ($0.44) earnings per share (EPS) for the quarter.
View Futura Medical's earnings history
.

How has Futura Medical's stock price been impacted by Coronavirus?

Futura Medical's stock was trading at GBX 11.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, FUM stock has increased by 256.9% and is now trading at GBX 39.70.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for FUM?

1 equities research analysts have issued 1 year price objectives for Futura Medical's stock. Their forecasts range from GBX 102 to GBX 102. On average, they anticipate Futura Medical's share price to reach GBX 102 in the next year. This suggests a possible upside of 156.9% from the stock's current price.
View analysts' price targets for Futura Medical
or view top-rated stocks among Wall Street analysts.

Who are Futura Medical's key executives?

Futura Medical's management team includes the following people:
  • Mr. James Henry Barder, CEO & Exec. Director (Age 61, Pay $309.31k)
  • Ms. Angela Hildreth, COO, Fin. Director, Company Sec. & Director
  • Mr. Kenneth William James, Head of R&D & Exec. Director (Age 68, Pay $248.22k)
  • Dr. William Duncan Potter, Chief Scientific Officer & Adviser to the Board (Age 73)

Who are some of Futura Medical's key competitors?

What other stocks do shareholders of Futura Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Futura Medical investors own include Indivior (INDV), Tullow Oil (TLW), Bigblu Broadband (BBB), Directa Plus (DCTA), Genel Energy (GENL), Lakehouse (LAKE), Petrel Resources (PET), The People's Operator (TPOP), (CITY.L) (CITY) and (PAYS.L) (PAYS).

What is Futura Medical's stock symbol?

Futura Medical trades on the London Stock Exchange (LON) under the ticker symbol "FUM."

How do I buy shares of Futura Medical?

Shares of FUM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Futura Medical's stock price today?

One share of FUM stock can currently be purchased for approximately GBX 39.70.

How much money does Futura Medical make?

Futura Medical has a market capitalization of £113.97 million and generates £31,778.00 in revenue each year.

How many employees does Futura Medical have?

Futura Medical employs 13 workers across the globe.

What is Futura Medical's official website?

The official website for Futura Medical is www.futuramedical.com.

Where are Futura Medical's headquarters?

Futura Medical is headquartered at 40 Surrey Technology Centre, Occam Road, GUILDFORD, GU2 7YG, United Kingdom.

How can I contact Futura Medical?

Futura Medical's mailing address is 40 Surrey Technology Centre, Occam Road, GUILDFORD, GU2 7YG, United Kingdom. The company can be reached via phone at +44-1483-685670.


This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.